相关实验视频

Updated: Sep 19, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

使用编码为CCR7,CXCL16和GITRL的脂质纳米粒子封装的mRNA有效地调动抗瘤T细胞免疫力

Jianyu Chen¹, Qingyan Cen¹, Rong Hu¹

¹Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510280, People's Republic of China.

International journal of biological macromolecules

|June 1, 2025

概括

这项研究开发了脂质纳米粒子封装的mRNA (LNP-mRNA) 来增强树突细胞 (DC) 功能并对抗免疫抑制瘤微环境 (TME). 伦普-mRNA疗法表现出强大的抗瘤作用,并与抗PD-1疗法协同作用.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

在瘤微环境 (TME) 中杀伤瘤细胞功能障碍会损害抗瘤免疫力.
像CCR7,CXCL16和GITRL这样的免疫调节剂提供了增强免疫疗法的潜力.
目前的免疫疗法在克服免疫抑制性TME方面面临挑战.

研究的目的:

开发和评估一种新型的脂质纳米粒子封装mRNA (LNP-mRNA) 疗法,编码CCR7,CXCL16和GITRL.
增强树突细胞 (DC) 免疫性和重塑免疫抑制TME.
评估LNP-mRNA在临床前瘤模型中的治疗潜力,包括组合疗法.

主要方法:

用LNP-mRNA进行DCs的体外刺激,以评估DC功能.
在LNP-mRNA给药后系统性免疫反应的表征.
在B16-OVA和人性化的Raji小鼠模型中评估抗瘤疗效,包括与抗PD-1抗体的组合.

主要成果:

LNP-mRNA显著增强了DC功能,并促进了T细胞激活和效应因子分化.
在内服药后,LNP-mRNA抑制了调控性T细胞透,并诱导了已建立瘤的回归.
结合LNP-mRNA和抗PD-1抗体,在人性化模型中协同增强了抗瘤免疫力.

结论:

开发的LNP-mRNA是一种多功能策略,可增强DC功能,T细胞初始化和TME重塑,以持久控制瘤.
这种方法代表了瘤免疫疗法的重大进步,通过克服有效抗瘤反应的关键障碍.
在癌症治疗中,LNP-mRNA疗法有望改善患者的治疗结果.

关键词:

CCR7 CCR7 CCR7 CCR7 CCR7 CCR7 CCR7 CCR7 CCR7 CCR7 CCR7 CCR7 在CXCL16中,CXCL16是CXCL16的代名词.树突性细胞树突性细胞在GITRL中,GITRL是指GITRL.免疫治疗是一种免疫疗法.mRNA疗法是一种mRNA疗法.

更多相关视频

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Radial Mobility and Cytotoxic Function of Retroviral Replicating Vector Transduced, Non-adherent Alloresponsive T Lymphocytes

Radial Mobility and Cytotoxic Function of Retroviral Replicating Vector Transduced, Non-adherent Alloresponsive T Lymphocytes

Published on: February 11, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.